arrow
H

Hanns Lochmüller

University of Ottawa
H指数:100
被引数:3.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Serglycin as a preliminary candidate biomarker in GNE myopathy associated with impaired secretion and autophagy dysregulation

Serglycin作为与分泌受损和自噬失调相关的GNE肌病的初步候选生物标志物

2026-09-090
OA
Systematic reanalysis of next-generation sequencing data in 101 neuromuscular disorder families enhances diagnostic yield, reveals intronic variants, and identifies a novel disease gene

对101个神经肌肉疾病家系下一代测序数据的系统性再分析提高了诊断率,揭示了内含子变异,并鉴定出一个新的疾病基因

2026-07-200
PRE
A muscular dystrophy associated with bi-allelic LEMD2 variants: Expanding the genotype of nuclear envelopathies

一种与双等位基因LEMD2变异相关的肌营养不良:扩展核包膜病的基因型

2026-03-030
OAAI
Results of a phase II open-label, multiple-dose study of vamorolone (VBP15-006) in 7- to < 18-year-old boys with duchenne muscular dystrophy

7至<18岁杜氏肌营养不良症男孩中vamorolone(VBP15-006)的II期开放标签、多次给药研究的成果

2026-03-030
OA
Treatment evolution in spinal muscular atrophy: insights from the SMArtCARE registry
Brain
IF11.7
2025-12-230
OAAI
EIPR1 variants cause a neurodevelopmental disorder with endolysosomal and dense core vesicle defects

EIPR1基因变异导致伴有内体-溶酶体和致密核心囊泡缺陷的神经发育障碍

Brain
IF11.7
2025-10-070
PRE
Phenotypic intrafamilial variability of 5q-associated spinal muscular atrophy: A systematic multicentre sibling study

5q相关脊髓性肌萎缩症的表型家族内变异性:一项系统性多中心同胞研究

2025-09-120
PRE